Lip GYH - Search Results

1

Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management).

Proietti M, Romiti GF, Olshansky B, Lip GYH. Proietti M, et al. Among authors: lip gyh. Hypertension. 2017 Nov;70(5):949-958. doi: 10.1161/HYPERTENSIONAHA.117.10106. Epub 2017 Oct 3. Hypertension. 2017. PMID: 28974568 Free article. Clinical Trial.

2

Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation.

Kamath S, Blann AD, Caine GJ, Gurney D, Chin BS, Lip GY. Kamath S, et al. Stroke. 2002 May;33(5):1237-42. doi: 10.1161/01.str.0000013739.82306.7f. Stroke. 2002. PMID: 11988597 Clinical Trial.

3

Antiarrhythmics in atrial fibrillation.

Freestone B, Lip GY. Freestone B, et al. Curr Opin Investig Drugs. 2002 Jan;3(1):84-8. Curr Opin Investig Drugs. 2002. PMID: 12054078 Review.

4

Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).

Spencer CG, Gurney D, Blann AD, Beevers DG, Lip GY; ASCOT Steering Committee, Anglo-Scandinavian Cardiac Outcomes Trial. Spencer CG, et al. Hypertension. 2002 Jul;40(1):61-6. doi: 10.1161/01.hyp.0000022061.12297.2e. Hypertension. 2002. PMID: 12105139 Clinical Trial.

5

Acute atrial fibrillation.

Freestone B, Kamath S, Lip G. Freestone B, et al. Clin Evid. 2002 Jun;(7):1-10. Clin Evid. 2002. Update in: Clin Evid. 2003 Jun;(9):61-71. PMID: 12230635 Updated. Review. No abstract available.

6

Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study.

Conway DS, Heeringa J, Van Der Kuip DA, Chin BS, Hofman A, Witteman JC, Lip GY. Conway DS, et al. Stroke. 2003 Feb;34(2):413-7. doi: 10.1161/01.str.0000051728.85133.32. Stroke. 2003. PMID: 12574552

7

Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment.

Felmeden DC, Spencer CG, Blann AD, Beevers DG, Lip GY. Felmeden DC, et al. Hypertension. 2003 Mar;41(3):528-33. doi: 10.1161/01.HYP.0000056997.40992.41. Epub 2003 Feb 24. Hypertension. 2003. PMID: 12623954

8

Pharmacological modulation of platelet function in hypertension.

Blann AD, Nadar S, Lip GY. Blann AD, et al. Hypertension. 2003 Jul;42(1):1-7. doi: 10.1161/01.HYP.0000077901.84467.E1. Epub 2003 Jun 2. Hypertension. 2003. PMID: 12782643 Review.

9

Fibrinolytic function and atrial fibrillation.

Marín F, Roldán V, Lip GY. Marín F, et al. Thromb Res. 2003 Mar 15;109(5-6):233-40. doi: 10.1016/s0049-3848(03)00259-7. Thromb Res. 2003. PMID: 12818244 Review.

10

More evidence on blocking the renin-angiotensin-aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2).

Lip GY, Beevers DG. Lip GY, et al. J Hum Hypertens. 2003 Nov;17(11):747-50. doi: 10.1038/sj.jhh.1001650. J Hum Hypertens. 2003. PMID: 14578913 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,632 results

Search Page

Filters